Loading...
HDAC inhibition as a treatment concept to combat temsirolimus-resistant bladder cancer cells
INTRODUCTION: Although the mechanistic target of rapamycin (mTOR) might be a promising molecular target to treat advanced bladder cancer, resistance develops under chronic exposure to an mTOR inhibitor (everolimus, temsirolimus). Based on earlier studies, we proposed that histone deacetylase (HDAC)...
Na minha lista:
| Udgivet i: | Oncotarget |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Impact Journals LLC
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5746361/ https://ncbi.nlm.nih.gov/pubmed/29299126 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.22454 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|